PL3949962T3 - Kompozycje przeciw infekcjom candida - Google Patents

Kompozycje przeciw infekcjom candida

Info

Publication number
PL3949962T3
PL3949962T3 PL21191588.9T PL21191588T PL3949962T3 PL 3949962 T3 PL3949962 T3 PL 3949962T3 PL 21191588 T PL21191588 T PL 21191588T PL 3949962 T3 PL3949962 T3 PL 3949962T3
Authority
PL
Poland
Prior art keywords
compositions against
against candida
candida infections
infections
compositions
Prior art date
Application number
PL21191588.9T
Other languages
English (en)
Inventor
Bruno Cammue
Karin Thevissen
Kaat DE CREMER
Paul COS
Original Assignee
Katholieke Universiteit Leuven
Universiteit Antwerpen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1711512.2A external-priority patent/GB201711512D0/en
Application filed by Katholieke Universiteit Leuven, Universiteit Antwerpen filed Critical Katholieke Universiteit Leuven
Publication of PL3949962T3 publication Critical patent/PL3949962T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/14Quaternary ammonium compounds, e.g. edrophonium, choline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4174Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL21191588.9T 2017-07-18 2018-07-05 Kompozycje przeciw infekcjom candida PL3949962T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1711512.2A GB201711512D0 (en) 2017-07-18 2017-07-18 Compositions against candida infections
LU100445 2017-09-20

Publications (1)

Publication Number Publication Date
PL3949962T3 true PL3949962T3 (pl) 2024-03-18

Family

ID=63012980

Family Applications (2)

Application Number Title Priority Date Filing Date
PL21191588.9T PL3949962T3 (pl) 2017-07-18 2018-07-05 Kompozycje przeciw infekcjom candida
PL18745504T PL3654973T3 (pl) 2017-07-18 2018-07-05 Kompozycje przeciwko zakażeniom Candida

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL18745504T PL3654973T3 (pl) 2017-07-18 2018-07-05 Kompozycje przeciwko zakażeniom Candida

Country Status (13)

Country Link
US (2) US11793790B2 (pl)
EP (2) EP3654973B1 (pl)
CY (1) CY1125444T1 (pl)
DK (1) DK3654973T3 (pl)
ES (2) ES2895653T3 (pl)
HR (1) HRP20211731T1 (pl)
HU (1) HUE056271T2 (pl)
LT (1) LT3654973T (pl)
PL (2) PL3949962T3 (pl)
PT (1) PT3654973T (pl)
RS (1) RS62502B1 (pl)
SI (1) SI3654973T1 (pl)
WO (1) WO2019015975A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116077499B (zh) * 2022-11-28 2024-10-29 徐州医科大学 一种抗耐唑型烟曲霉的药物组合物及其应用
KR20260049629A (ko) * 2023-08-08 2026-04-14 카톨리에케 유니버시테이트 루벤 세균성 질염 치료에 사용하기 위한 조성물
WO2026027529A1 (en) 2024-07-29 2026-02-05 Fhp Bv Compositions for treating vaginal candida (biofilm) infections with improved relapse prevention

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU513753B2 (en) 1974-07-08 1980-12-18 Johnson & Johnson Antimicrobial composition
ATE70158T1 (de) * 1985-09-24 1991-12-15 Ss Pharmaceutical Co Fungizides mittel.
CA2223747A1 (en) * 1995-06-07 1996-12-19 Taisho Pharmaceutical Co., Ltd. Antifungal compositions
US7868162B2 (en) * 1998-12-30 2011-01-11 Lakewood-Amedex, Inc. Antimicrobial and antiviral compounds and methods for their use
IL143477A (en) * 2001-05-31 2009-07-20 Finetech Pharmaceutical Ltd Process for the preparation of 17-phenyl-18,19,20-trinor-pgf2?? and its derivatives
US6727244B2 (en) * 2000-10-26 2004-04-27 Merck & Co., Inc. Mammalian metabolites of a tachykinin receptor antagonist
EP3089750A2 (en) * 2014-01-02 2016-11-09 Cook Medical Technologies LLC Compositions, devices and methods for treating infections
US9782333B2 (en) * 2015-01-21 2017-10-10 Chattem Inc. Oral composition for xerostomia

Also Published As

Publication number Publication date
WO2019015975A1 (en) 2019-01-24
LT3654973T (lt) 2021-11-25
US20230414570A1 (en) 2023-12-28
US11793790B2 (en) 2023-10-24
HRP20211731T1 (hr) 2022-02-18
HUE056271T2 (hu) 2022-02-28
SI3654973T1 (sl) 2021-12-31
DK3654973T3 (da) 2021-11-15
PL3654973T3 (pl) 2022-01-17
CY1125444T1 (el) 2023-03-24
US12329743B2 (en) 2025-06-17
EP3654973B1 (en) 2021-08-18
EP3949962A1 (en) 2022-02-09
EP3654973A1 (en) 2020-05-27
ES2895653T3 (es) 2022-02-22
PT3654973T (pt) 2021-10-15
RS62502B1 (sr) 2021-11-30
US20200138786A1 (en) 2020-05-07
EP3949962B1 (en) 2023-09-13
EP3949962C0 (en) 2023-09-13
ES2960745T3 (es) 2024-03-06

Similar Documents

Publication Publication Date Title
EP3722358A4 (en) COMPOSITION
DK3697376T3 (da) Sammensætning
EP3534968A4 (en) ANTI-BCMA T CAR LYMPHOCYTE COMPOSITIONS
MA52546A (fr) Compositions ciblées
EP3606559C0 (en) BIOORTHOGONAL COMPOSITIONS
EP3493800A4 (en) CANNABIS
DK3416996T3 (da) Hærdelig sammensætning
EP3464424A4 (en) PAI-BASED COATING COMPOSITIONS
EP3498811A4 (en) TENSIDE COMPOSITION
EP3697866A4 (en) ENGRAVING COMPOSITIONS
DK3528902T3 (da) Ringegelsammensætning
LT3651736T (lt) Ilgai veikiančios kompozicijos
EP3430073A4 (en) COMPOSITION BASED ON A POLYARYLETHERKETONE COMPOSITION
EP3443078A4 (en) ANTIMICROBIAL COMPOSITIONS
EP3589716A4 (en) ADHESION IMPROVEMENT COMPOSITIONS
DK4234656T3 (da) Sammensætninger
EP3458041A4 (en) ANTIBACTERIAL COMPOSITIONS
DK3451829T3 (da) Antimikrobielle sammensætninger
EP3480228A4 (en) COMPOSITION
DK3528791T3 (da) Dispergible sammensætninger
EP3548044A4 (en) ARSENIC COMPOSITIONS
PT3765379T (pt) Composições
EP3681468C0 (en) ANTIMICROBIAL COMPOSITION
EP3524627A4 (en) COMPOSITION
PL3949962T3 (pl) Kompozycje przeciw infekcjom candida